Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.220
+0.070 (3.26%)
At close: Jun 6, 2025, 4:00 PM
2.250
+0.030 (1.35%)
After-hours: Jun 6, 2025, 7:58 PM EDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of $90.69 million as of June 6, 2025. Its market cap has decreased by -3.42% in one year.
Market Cap
90.69M
Enterprise Value
-39.65M
1-Year Change
-3.42%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since May 31, 2007, Oramed Pharmaceuticals's market cap has increased from $29.90M to $90.69M, an increase of 203.30%. That is a compound annual growth rate of 6.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 90.70M | -7.07% |
| Dec 31, 2024 | 97.60M | 4.72% |
| Dec 29, 2023 | 93.20M | -80.20% |
| Dec 30, 2022 | 470.60M | -13.48% |
| Dec 31, 2021 | 543.90M | 441.73% |
| Dec 31, 2020 | 100.40M | 12.05% |
| Dec 31, 2019 | 89.60M | 71.98% |
| Dec 31, 2018 | 52.10M | -59.55% |
| Dec 29, 2017 | 128.80M | 58.62% |
| Dec 30, 2016 | 81.20M | -18.15% |
| Dec 31, 2015 | 99.20M | 115.18% |
| Dec 31, 2014 | 46.10M | -62.40% |
| Dec 31, 2013 | 122.60M | 330.18% |
| Dec 31, 2012 | 28.50M | 45.41% |
| Dec 30, 2011 | 19.60M | 11.36% |
| Dec 31, 2010 | 17.60M | -31.52% |
| Dec 31, 2009 | 25.70M | 16.82% |
| Dec 31, 2008 | 22.00M | 83.33% |
| Dec 31, 2007 | 12.00M | -59.87% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.04B |
| Johnson & Johnson | 372.10B |
| AbbVie | 335.40B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 273.60B |
| Abbott Laboratories | 232.44B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |